All filters
Slidesets
Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD
Presented at:
RespiDART 2018
Slidesets
Abstract: SB 9200 is a novel broad-spectrum antiviral agent effective against both RSV and Flu (#101) | Diane Schmidt
Presented at:
RespiDART 2018
Slidesets
Abstract: Structure-based prediction of influenza resistance mutations (#102) | Bryan Cox
Presented at:
RespiDART 2018
Slidesets
3D Human epithelial models to study respiratory virus pathogenesis | Samuel Constant, PhD
Presented at:
RespiDART 2018
Slidesets
Abstract: Risk factors for RSV severity in immunocompetent and immunocompromised adults presenting in an emergency department (#103) | Slim Fourati
Presented at:
RespiDART 2018
Slidesets
Abstract: Non-targeted diagnosis of multiple viral infections by means of shotgun metagenomic using deep sequencing (#104) | Slim Fourati, PhD
Presented at:
RespiDART 2018
Slidesets
Plenary Lecture: Opportunities and Challenges for a Broadly Protective Influenza Vaccine | Gary Nabel, MD
Presented at:
RespiDART 2018
Slidesets
RV521: A new and potent RSV fusion inhibitor in clinical development | Stuart Cockerill, PhD
Presented at:
RespiDART 2018
Slidesets
Cocrystal Pharma: Influenza drug pipeline design | Sam Lee, PhD
Presented at:
RespiDART 2018
Slidesets
Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD
Presented at:
RespiDART 2018
Videos
Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD
Presented at:
RespiDART 2018
Videos
3D Human epithelial models to study respiratory virus pathogenesis | Samuel Constant, PhD
Presented at:
RespiDART 2018
Videos
Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD
Presented at:
RespiDART 2018
Videos
RV521: A new and potent RSV fusion inhibitor in clinical development | Stuart Cockerill, PhD
Presented at:
RespiDART 2018